NEU 3.50% $14.05 neuren pharmaceuticals limited

Rett, page-6

  1. 194 Posts.
    This decision is not about the shareholders; it is really about the sufferers and their families; they are the ones who will get the real benefit if the FDA approve the BTD application. If the FDA do approve the biggest should go to the sufferers and their families.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.